Showing 181 - 200 results of 428 for search '"inherited metabolic diseases"', query time: 0.12s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186

    Clinical, diagnostic and therapeutic characteristics of mucopolysaccharidosis by John Sebastián Carvajal Gavilanes, José Andrés Plazarte Mullo, Marcia Alexandra Silva Mata

    Published 2023-04-01
    “…Conclusions: Mucopolysaccharidoses are a group of inherited metabolic diseases. In mucopolysaccharidosis an adequate diagnosis is essential to improve the life expectancy of patients. …”
    Get full text
    Article
  7. 187

    Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) by P. N. Vlasov

    Published 2018-12-01
    “…VA should not be used (if the clinical situation allows) in women of childbearing age, in some infantile epileptic encephalopathy, inherited metabolic diseases, and chromosomal abnormalities. …”
    Get full text
    Article
  8. 188

    Evaluation of patients with phenylketonuria before and after screening in Qazvin Province, Iran by Ali Homaei

    Published 2021-11-01
    “…CONCLUSION: Early diagnosis and treatment of children with inherited metabolic diseases can prevent brain damage and retardation in them and reduce the financial and psychological burden of treating these children by maintaining their intelligence quotient (IQ).…”
    Get full text
    Article
  9. 189

    Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain by A.R. Silva, C. Ruschel, C. Helegda, A.T.S. Wyse, C.M.D. Wannmacher, M. Wajner, C.S. Dutra-Filho

    Published 2001-05-01
    “…2-Hydroxybutyric acid appears at high concentrations in situations related to deficient energy metabolism (e.g., birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as "cerebral" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. …”
    Get full text
    Article
  10. 190
  11. 191
  12. 192

    Clinical proton MR spectroscopy in central nervous system disorders. by Oz, G, Alger, JR, Barker, P, Bartha, R, Bizzi, A, Boesch, C, Bolan, P, Brindle, K, Cudalbu, C, Dinçer, A, Dydak, U, Emir, U, Frahm, J, González, R, Gruber, S, Gruetter, R, Gupta, R, Heerschap, A, Henning, A, Hetherington, H, Howe, F, Hüppi, P, Hurd, R, Kantarci, K, Klomp, D

    Published 2014
    “…The clinical usefulness of (1)H MR spectroscopy has been established for brain neoplasms, neonatal and pediatric disorders (hypoxia-ischemia, inherited metabolic diseases, and traumatic brain injury), demyelinating disorders, and infectious brain lesions. …”
    Journal article
  13. 193
  14. 194
  15. 195

    Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease by Max Arslan, Max Novak, Dietmar Rosenthal, Christian J. Hartmann, Philipp Albrecht, Sara Samadzadeh, Harald Hefter

    Published 2022-09-01
    “…A family is described as having two recessively inherited metabolic diseases and three differently affected children. …”
    Get full text
    Article
  16. 196

    Postpyloric nutrition to prevent emergencies – a step away from repeat inpatient care in children with methylmalonic acidaemia and propionic acidaemia – a case report of four cases... by Stefan Schumann, Frank Risto Rommel, Serdar Cantez, Evdokia Alexanidou, Clemens Kamrath, Jan de Laffolie

    Published 2023-02-01
    “…Methylmalonic acidaemia (MMA) and propionic acidaemia (PA) are very rare autosomal recessive inherited metabolic diseases from the group of organoacidopathies. …”
    Get full text
    Article
  17. 197

    Training competencies in adult metabolic medicine: A survey of working adult metabolic medicine physicians by Sandra Sirrs, Elisa Fabbro, Annalisa Sechi, for the SSIEM Adult Metabolic Medicine Training Competencies Working Group

    Published 2022-09-01
    “…Abstract The rapid expansion of the number of adult patients with inherited metabolic diseases (IMDs) has created demand for physicians with expertise in the field of adult metabolic medicine (AMM). …”
    Get full text
    Article
  18. 198

    Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications by Karolina Pierzynowska, Lidia Gaffke, Zuzanna Cyske, Grzegorz Węgrzyn, Brigitta Buttari, Elisabetta Profumo, Luciano Saso

    Published 2021-09-01
    “…Although mucopolysaccharidoses (MPS) are caused by mutations in genes coding for enzymes responsible for degradation of glycosaminoglycans, storage of these compounds is crucial but is not the only pathomechanism of these severe, inherited metabolic diseases. Among various factors and processes influencing the course of MPS, oxidative stress appears to be a major one. …”
    Get full text
    Article
  19. 199

    Lysosomal storage disorders: Molecular basis and laboratory testing by Filocamo Mirella, Morrone Amelia

    Published 2011-03-01
    “…<p>Abstract</p> <p>Lysosomal storage disorders (LSDs) are a large group of more than 50 different inherited metabolic diseases which, in the great majority of cases, result from the defective function of specific lysosomal enzymes and, in cases, of non-enzymatic lysosomal proteins or non-lysosomal proteins involved in lysosomal biogenesis. …”
    Get full text
    Article
  20. 200

    Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice. by te Vruchte, D, Jeans, A, Platt, F, Sillence, D

    Published 2010
    “…Glycosphingolipid storage diseases are a group of inherited metabolic diseases in which glycosphingolipids accumulate due to their impaired lysosomal breakdown. …”
    Journal article